Managing High-Risk NMIBC

The treatment landscape for high-risk non–muscle-invasive bladder cancer (NMIBC) is rapidly evolving. This resource aims to equip you with the information you need to select the right treatment options for your patients, with focused overviews of diagnostic and treatment pathways, plus the latest from this year’s major congresses: ASCO GU, EAU, AUA, ASCO, and ESMO.